Novel Treatments for Hearing Loss Collaboration and licensing agreement to advance novel therapies for sensorineural hearing loss (SNHL), where there are currently no approved pharmacological therapies. OKLAHOMA CITY–(BUSINESS WIRE)– Autigen, a biotechnology portfolio company of the pharmaceutical accelerator, Ascend BioVentures, developing novel treatments for hearing loss, announced today that it has signed a research collaboration and license agreementRead more
News
By Scott Meacham It is always amazing to me how often entrepreneurship and life-changing innovations come out of parents’ love and concern for their children’s health. That’s the back story on PhotoniCare, a young company that provides a ground-breaking imaging technology, called the TOMi™ Scope, which allows physicians, for the first time ever, to non-invasivelyRead more
